Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pearson

Showing results (1141-1150 of 1,153) with videos related to

Pageof 116
Sort By:
American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.
Journal of Research of the National Institute of Standards and Technology|July 23, 2016
A Critical Evaluation of Interlaboratory Data on Total, Elemental, and Isotopic Carbon in the Carbonaceous Particle Reference Material, NIST SRM 1649aL A Currie, B A Benner, J D Kessler, et al.
JACC. Advances|February 20, 2024
The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health DisparitiesThomas A Pearson, Debbie Vitalis, Charlotte Pratt, et al.
The New England Journal of Medicine|March 15, 2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt, Keith A A Fox, Werner Hacke, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
British Journal of Cancer|December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)G Schleiermacher, J Michon, A Ribeiro, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial EndpointsLatha Valluripalli Soorya, Camille W Brune, Cristan A Farmer, et al.
Nature|January 28, 2016
The genome of the seagrass Zostera marina reveals angiosperm adaptation to the seaJeanine L Olsen, Pierre Rouzé, Bram Verhelst, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunityBenjamin J Jenkins, Yasmin R Jenkins, Fernando M Ponce-Garcia, et al.
Pageof 116

Showing results (1141-1150 of 1,153) with videos related to

Sort By:
Pageof 116
American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.
Journal of Research of the National Institute of Standards and Technology|July 23, 2016
A Critical Evaluation of Interlaboratory Data on Total, Elemental, and Isotopic Carbon in the Carbonaceous Particle Reference Material, NIST SRM 1649aL A Currie, B A Benner, J D Kessler, et al.
JACC. Advances|February 20, 2024
The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health DisparitiesThomas A Pearson, Debbie Vitalis, Charlotte Pratt, et al.
The New England Journal of Medicine|March 15, 2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt, Keith A A Fox, Werner Hacke, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
British Journal of Cancer|December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)G Schleiermacher, J Michon, A Ribeiro, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial EndpointsLatha Valluripalli Soorya, Camille W Brune, Cristan A Farmer, et al.
Nature|January 28, 2016
The genome of the seagrass Zostera marina reveals angiosperm adaptation to the seaJeanine L Olsen, Pierre Rouzé, Bram Verhelst, et al.
BMJ Open|February 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trialMartin John Connor, Taimur Tariq Shah, Katarzyna Smigielska, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunityBenjamin J Jenkins, Yasmin R Jenkins, Fernando M Ponce-Garcia, et al.
Pageof 116